Skip to main content
Clinical Trials/DRKS00010052
DRKS00010052
Completed
N/A

Tailored physical activity interventions for the promotion of healthy ageing - PROMOTE

eibniz-Institut für Präventionsforschung und Epidemiologie - BIPS0 sites589 target enrollmentJuly 11, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
physical activity
Sponsor
eibniz-Institut für Präventionsforschung und Epidemiologie - BIPS
Enrollment
589
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 11, 2016
End Date
December 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
eibniz-Institut für Präventionsforschung und Epidemiologie - BIPS

Eligibility Criteria

Inclusion Criteria

  • Principal residence in one of the eight communities in the metropolitan region of Bremen\-Oldenburg
  • \-Informed consent for study participation
  • \-Device with internet access and e\-mail\-address available in the household
  • \-Ability to live independently (own apartment or room without assisted living, no classification into care levels)
  • \-Basics knowledge of German
  • \-Study participants can participate in baseline and follow\-up assessments and in group meetings on their own
  • \-Study participant is able to walk without a walker or other walking aid)

Exclusion Criteria

  • \-Planned vacation \> one month
  • \-Note from primary care physician prohibiting any PA
  • \-Cognitive impairment (Mini\-Mental\-Score \=27\)
  • \-Permanent impairments due to a stroke or a transient ischemic attack (TIA)
  • \-Permanent impairments due to a brain surgery
  • \-Neurological diseases, such as Alzheimer dementia, Parkinson’s, Multiple Sclerosis
  • \-Impairments due to an acute spine injury
  • \-Fractures/surgeries in the past six months which may limit the ability to participate in the interventions (if no medical clearance is provided)
  • \-Severe diseases of the cardiovascular system (e.g., cardiac arrhythmia, arterial occlusive disease, heart failure, pacemaker, hypertension) (if no medical clearance is provided)
  • \-Severe diseases of the respiratory system (e.g., COPD, severe asthma, pulmonary hypertension) (if no medical clearance is provided)

Outcomes

Primary Outcomes

Not specified

Similar Trials